Home » Topics » Regulatory

Regulatory
RSS

FDA approves Valturna, a single-pill combination of aliskiren and valsartan

Sep. 18, 2009

Theravance and Astellas obtain FDA approval of Vibativ

Sep. 16, 2009

Lumavita is granted marketing authorization in Switzerland for pentamycin for vaginitis

Sep. 1, 2009

FDA approves Embeda for moderate to severe chronic pain

Aug. 17, 2009

Saphris approved by FDA for schizophrenia and bipolar I disorder

Aug. 17, 2009

Invega approved for the treatment of schizoaffective disorder

Aug. 6, 2009

Invega Sustenna approved for acute and maintenance schizophrenia treatment

Aug. 5, 2009

FDA approves AstraZeneca and Bristol-Myers' Onglyza for type 2 diabetes

Aug. 4, 2009

Wyeth's Prevenar 13 pneumococcal vaccine approved in Chile

July 16, 2009

FDA granted marketing approval for AMAG's Feraheme in chronic kidney disease

July 1, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...